Literature DB >> 8601522

Angiogenesis in uterine cervical squamous cell carcinoma.

J L Rutgers1, T F Mattox, M P Vargas.   

Abstract

This study tested the hypothesis that increased angiogenesis in squamous cell carcinoma of the cervix is an indicator of poor prognosis. We retrospectively studied 70 cases and related the microvessel count to stage and follow-up. We performed immunohistochemical staining for Factor VIII and counted the number of microvessels in a 400x field in the area of greatest density of vessels. The mean vessel count in stage I was 18.3 +/- 5.4 (26 cases), in stage II 18.0 +/- 6.8 (21 cases), in stage III 17.9 +/- 3.9 (18 cases), and in stage IV 22.2 +/- 13.6 (five cases). We found no correlation between the mean vessel count and stage (p < 0.85) or between mean vessel count and disease status on an average follow-up of 21 months (p < 0.65). With a power of approximately 70%, this study excludes the hypothesis that an increased density of microvessels is associated with a worsened prognosis in cervical squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8601522     DOI: 10.1097/00004347-199504000-00004

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  9 in total

Review 1.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

2.  Lack of correlation between microvascular density and pathological features and outcomes in sinonasal and oral mucosal melanomas.

Authors:  Elizabeth H Kerr; Dezhi Wang; James S Lewis; Nasser Said-Al-Naief; Omar Hameed
Journal:  Head Neck Pathol       Date:  2011-03-19

3.  Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.

Authors:  Leslie M Randall; Bradley J Monk; Kathleen M Darcy; Chunqiao Tian; Robert A Burger; Shu-Yuan Liao; William A Peters; Richard J Stock; John P Fruehauf
Journal:  Gynecol Oncol       Date:  2008-12-24       Impact factor: 5.482

4.  Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia.

Authors:  S P Dobbs; P W Hewett; I R Johnson; J Carmichael; J C Murray
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.

Authors:  W Tjalma; E Van Marck; J Weyler; L Dirix; A Van Daele; G Goovaerts; G Albertyn; P van Dam
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

6.  Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.

Authors:  J Fujimoto; H Sakaguchi; R Hirose; S Ichigo; T Tamaya
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

Review 7.  Angiogenesis and antiangiogenic agents in cervical cancer.

Authors:  Federica Tomao; Anselmo Papa; Luigi Rossi; Eleonora Zaccarelli; Davide Caruso; Federica Zoratto; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  Onco Targets Ther       Date:  2014-12-03       Impact factor: 4.147

8.  Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy.

Authors:  Leonardo Rojas-Puentes; Andrés F Cardona; Hernán Carranza; Carlos Vargas; Luis F Jaramillo; Delma Zea; Lucely Cetina; Beatriz Wills; Erika Ruiz-Garcia; Oscar Arrieta
Journal:  Cancer Med       Date:  2016-05-27       Impact factor: 4.452

9.  Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis.

Authors:  Weili Li; Cong Liang; Ping Liu; Yingying Qi; Hong Shen; Mingwei Li; Chunlin Chen
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.